Unassociated Document
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
 
March 4, 2011 (March 4, 2011)
 

 
HARRIS & HARRIS GROUP, INC.

 
(Exact name of registrant as specified in its charter)
         
New York
(State or other jurisdiction of
incorporation)
 
0-11576
(Commission File
Number)
 
13-3119827
(IRS Employer
Identification No.)


 
1450 Broadway
New York, New York 10018

 
(Address of principal executive offices and zip code)
 
(212) 582-0900

 
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

 

Item 7.01.     Regulation FD Disclosure.

On March 4, 2011, Harris & Harris Group, Inc. (the “Company”) issued a press release disclosing that Amgen and BioVex Group, Inc., had announced the completion of Amgen’s acquisition of BioVex Group.  The Company was an investor in privately held BioVex Group.  A copy of the Company's press release issued March 4, 2011, is attached as Exhibit 99.1.


Item 9.01.    Financial Statements and Exhibits.

 
(a)
Not applicable.
     
 
(b)
Not applicable.
     
 
(c)
Not applicable.
     
 
(d)
Exhibits.


 
Exhibit No.
Description
 
       
 
99.1
Press Release, dated March 4, 2011
 

 
 

 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date:
March 4, 2011
HARRIS & HARRIS GROUP, INC.
 
       
       
       
   
By: /s/ Douglas W. Jamison
 
   
Douglas W. Jamison
 
   
Chief Executive Officer
 



 
 

 

EXHIBIT INDEX


 
Exhibit No.
Description
 
       
 
99.1
Press Release, dated March 4, 2011